Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Salamat Ali, Mashhood Ali, Vibhu Paudyal, Faisal Rasheed, Shahan Ullah, Sayeed Haque & Tofeeq Ur-Rehman. (2019) A Randomized Controlled Trial to Assess the Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients. Patient Preference and Adherence 13, pages 2089-2100.
Read now
Read now
Vasily Isakov, Vladimir Chulanov, Dzhamal Abdurakhmanov, Eduard Burnevich, Elena Nurmukhametova, Galina Kozhevnikova, Natalya Gankina, Sergey Zhuravel, Svetlana Romanova, Robert H. Hyland, Sophia Lu, Evguenia S. Svarovskaia, John McNally, Diana M. Brainard, Vladimir Ivashkin, Vyacheslav Morozov, Igor Bakulin, Martin Lagging, Konstantin Zhdanov & Ola Weiland. (2019) Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden. Infectious Diseases 51:2, pages 131-139.
Read now
Read now
Articles from other publishers (11)
Adrian Farrugia, Renae Fomiatti, Suzanne Fraser, David Moore, Michael Edwards, Elizabeth Birbilis & Carla Treloar. (2022) Hepatitis C cure as a ‘gathering’: Attending to the social and material relations of hepatitis C treatment. Sociology of Health & Illness 44:4-5, pages 830-847.
Crossref
Crossref
Allison Dormanesh, Judy Huei-yu Wang, Ranit Mishori, Paula Cupertino, Joshua Longcoy, Seble Kassaye, Linda Kaljee, Coleman Smith & Christopher A. Loffredo. (2021) Adherence to clinical follow-up recommendations for liver function tests: A cross-sectional study of patients with HCV and their associated risk behaviors. Preventive Medicine Reports 23, pages 101482.
Crossref
Crossref
Nicolò de Gennaro, Lucia Diella, Laura Monno, Gioacchino Angarano, Michele Milella & Annalisa Saracino. (2020) Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders. BMC Infectious Diseases 20:1.
Crossref
Crossref
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Takeshi Kinbara, Tomoaki Fujikawa, Tsuyoshi Nakayama, Hiroki Yamanoue, Takayuki Kanemaru, Tohru Hashimotoh, Ji Hyun Sung, Makoto Kako & Wasaburo Koizumi. (2019) Efficacy and Tolerability of Ombitasvir/Paritaprevir/Ritonavir in HCV Genotype 1-infected Elderly Japanese Patients. Annals of Hepatology 18:1, pages 109-115.
Crossref
Crossref
Suzana Muller, Aline Patricia Brietzke, Deivid Cruz dos Santos, Michelle Moraes Jacinto, Matheus Truccolo Michalczuk & Mário Reis Álvarez-da-Silva. (2019) The Evaluation of Medication Adherence in Patients Infected With HCV Receiving Protease Inhibitors. Gastroenterology Nursing 42:3, pages 259-268.
Crossref
Crossref
S. D. Shafran, D. Shaw, M. Charafeddine, K. Agarwal, G. R. Foster, M. Abunimeh, T. Pilot-Matias, R. K. Pothacamury, B. Fu, E. Cohen, D. E. Cohen & E. Gane. (2018) Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II-III). Journal of Viral Hepatitis 25:2, pages 118-125.
Crossref
Crossref
Zachary DeNardo, Minha Choi, Michelle Stiller & Dillon Buechel. (2017) Cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation. The Kaohsiung Journal of Medical Sciences 33:11, pages 584-585.
Crossref
Crossref
Elyse Swallow, Jinlin Song, Yong Yuan, Anupama Kalsekar, Caroline Kelley, Fan Mu, Soomi Kim, Stephanie Noviello & James Signorovitch. (2016) Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison. Journal of Comparative Effectiveness Research 5:2, pages 129-139.
Crossref
Crossref
Diana H. Ferreira, José P. Silva, Stephen Quinn, Amy P. Abernethy, Miriam J. Johnson, Stephen G. Oxberry & David C. Currow. (2016) Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness—An Exploratory Study. Journal of Pain and Symptom Management 51:2, pages 247-254.
Crossref
Crossref
Elyse Swallow, Jinlin Song, Yong Yuan, Anupama Kalsekar, Caroline Kelley, Miranda Peeples, Fan Mu, Peter Ackerman & James Signorovitch. (2016) Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison. Clinical Therapeutics 38:2, pages 404-412.
Crossref
Crossref
Raíssa Neves Fagundes, Lincoln Eduardo Villela Vieira de Castro Ferreira & Fábio Heleno de Lima Pace. (2015) Health-Related Quality of Life in patients with hepatitis C in double and triple therapy. Revista da Escola de Enfermagem da USP 49:6, pages 937-943.
Crossref
Crossref